IDENTIFICATION AND CIRCUMVENTION OF RESISTANCE AFTER DONOR-DERIVED EX VIVO EXPANDED NK CELLS AND HAPLO-HCT IN CHILDREN AND YOUNG ADULTS WITH HIGH-RISK AML
$1,339,955FY2025Defense Health AgencyDOD
Research Institute At Nationwide Children'S Hospital
Research Institute At Nationwide Children'S Hospital